August 14, 2009 - Lantheus Medical Imaging will continue to allocate its Mo-99 supply to serve as many people as possible, said the company today in response to the statement issued by AECL regarding the extended shutdown of the NRU reactor Aug. 12.
August 14, 2009 – Philips is currently introducing its Xcelera R3.1 cardiology informatics system, which has new telecardiology capabilities to support clinical workflow and help provide faster sharing capabilities for cardiac patient information.
August 14, 2009 – ZOLL Medical Corp. said today Basingstoke and North Hampshire Hospital in Hampshire, United Kingdom, is the first hospital to install the AutoPulse Noninvasive Cardiac Support Pump in the cardiac catheterization laboratory in the U.K.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
August 14, 2009 – Unity Health System-Park Ridge in Rochester, N.Y., upgraded its OB-Windows systems with two OBLinks, providing instant, electronic transmission of patient data from ultrasound systems to Digisonics OB-View/OB-Windows systems eliminating human input error and increasing efficiency.
August 13, 2009 - The Canadian Prime Minister Stephen Harper expressed disappointment with reports from the Atomic Energy of Canada Ltd. (AECL) that the aging nuclear reactor at Chalk River, Ontario, which produces most of the medical isotopes for Canada and the United States, will not be back up and running until the spring of 2010.
August 13, 2009 – Abbott today announced the expansion of the company's XIENCE V USA post-approval study designed to evaluate the safety and effectiveness of the company's XIENCE V Everolimus-Eluting Coronary Stent System in a real-world clinical setting out to five years.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
August, 13, 2009 – Atherotech Inc. this week added two new cardiometabolic tests – the PLAC Test for identification of increased heart attack and stroke risk, and the Cystatin C test as an early, sensitive marker for chronic kidney disease.
August 13, 2009 – The pharmaceutical and healthcare research firm Decision Resources found Merck/Schering-Plough's Zetia and Vytorin lost substantial patient share in second- and third-line therapy since last.
August 13, 2009 – Data published today in the Journal of the American College of Cardiology (JACC) indicates percutaneous valve repair with the MitraClip therapy can reduce acute mitral regurgitation (MR) with sustained freedom from death, surgery or recurrent MR in a substantial proportion of functional and degenerative MR patients.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
August 12, 2009 - The Food and Drug Administration's (FDA) top medical-device regulator, Daniel Schultz, M.D., director of the FDA Center for Devices and Radiological Health, announced his resignation.
August 12, 2009 – The Cardiovascular Research Foundation announced today the late breaking trials that will be presented at Transcatheter Cardiovascular Therapeutics (TCT) 2009 symposium Sept. 21-25 in San Francisco.
August 12, 2009 – Abiomed Inc. said a webcast of an Impella 2.5 procedure performed on an 85-year-old man with multivessel disease at Mount Sinai Medical Center, now available and archived on the Abiomed Web site www.abiomed.com.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
August 12, 2009 – Researchers at the Georgia Institute of Technology, collaborating with pediatric cardiologists and surgeons at The Children's Hospital of Philadelphia, have developed a tool for virtual surgery that allows heart surgeons to view the predicted effects of different surgical approaches by manipulating 3D cardiac MRIs of a patient's specific anatomy.
August 11, 2009 – Pathway Medical Technologies Inc. today introduced the 7 French compatible version of its peripheral atherectomy catheter, the Jetstream G2 NXT.
August 11, 2009 – Physicians in the United Kingdom yesterday completed patient implants using the first CE mark approved drug-eluting stent designed specifically to treat severe peripheral artery disease (PAD) blockages in the challenging and largest artery in the leg.